Muscular Dystrophy: Medical Treatments

(asked on 11th October 2016) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what new treatments for Duchenne muscular dystrophy have been notified to the Horizon Scanning Research and Intelligence Centre in the last 12 months.


This question was answered on 19th October 2016

In the last 12 months, the National Institute for Health Research Horizon Scanning Research and Intelligence Centre has identified and added to its database the following technologies for which Duchenne muscular dystrophy is an indication:

- ezutromid;

- FG-3019;

- follistatin;

- halofuginone hydrobromide;

- SRP-4045;

- SRP-4053; and

- vamorolone.

Reticulating Splines